01 6Bristol-Myers Squibb Canada
02 8Gilead Sciences Canada Inc.
03 4Gowling Lafleur Henderson LLP
01 12075189
02 52101572
03 12104399
04 12105486
05 12261619
06 52279198
07 12298059
08 22332876
09 12512475
01 10Efavirenz
02 8Efavirenz | Emtricitabine | Tenofovir Disoproxil Fumarate
01 4Capsule
02 14Tablet
01 12011-01-31
02 12012-02-20
03 12012-03-05
04 52013-07-29
05 12017-07-25
06 52018-02-02
07 12018-07-23
08 22019-05-24
09 12024-01-13
Patent Expiration Date : 2018-02-02
Date Granted : 2009-04-14
Brand Name : SUSTIVA
Patent Number : 2279198
Filing Date : 1998-02-02
Strength per Unit : 200 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-02-02
Date Granted : 2009-04-14
Patent Expiration Date : 2018-02-02
Date Granted : 2009-04-14
Brand Name : SUSTIVA
Patent Number : 2279198
Filing Date : 1998-02-02
Strength per Unit : 300mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-02-02
Date Granted : 2009-04-14
Patent Expiration Date : 2019-05-24
Date Granted : 2008-07-08
Brand Name : SUSTIVA
Patent Number : 2332876
Filing Date : 1999-05-24
Strength per Unit : 300mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2019-05-24
Date Granted : 2008-07-08
Patent Expiration Date : 2018-02-02
Date Granted : 2009-04-14
Brand Name : SUSTIVA
Patent Number : 2279198
Filing Date : 1998-02-02
Strength per Unit : 600mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-02-02
Date Granted : 2009-04-14
Patent Expiration Date : 2019-05-24
Date Granted : 2008-07-08
Brand Name : SUSTIVA
Patent Number : 2332876
Filing Date : 1999-05-24
Strength per Unit : 600mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2019-05-24
Date Granted : 2008-07-08
Patent Expiration Date : 2018-02-02
Date Granted : 2009-04-14
Brand Name : SUSTIVA
Patent Number : 2279198
Filing Date : 1998-02-02
Strength per Unit : 50 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-02-02
Date Granted : 2009-04-14
Patent Expiration Date : 2011-01-31
Date Granted : 2004-11-30
Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate
Brand Name : ATRIPLA
Patent Number : 2075189
Filing Date : 1991-01-31
Strength per Unit : 600mg, 200mg, 300mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2011-01-31
Date Granted : 2004-11-30
Patent Expiration Date : 2017-07-25
Date Granted : 2006-05-23
Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate
Brand Name : ATRIPLA
Patent Number : 2261619
Filing Date : 1997-07-25
Strength per Unit : 600mg, 200mg, 300mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-07-25
Date Granted : 2006-05-23
Patent Expiration Date : 2013-07-29
Date Granted : 2001-08-28
Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate
Brand Name : ATRIPLA
Patent Number : 2101572
Filing Date : 1993-07-29
Strength per Unit : 600mg, 200mg, 300mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2013-07-29
Date Granted : 2001-08-28
Patent Expiration Date : 2012-02-20
Date Granted : 2005-10-18
Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate
Brand Name : ATRIPLA
Patent Number : 2104399
Filing Date : 1992-02-20
Strength per Unit : 600mg, 200mg, 300mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2012-02-20
Date Granted : 2005-10-18
